| RS886043378 |
PYCR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypomyelinating leukodystrophy 10, Hypomyelinating leukodystrophy 10 |
| RS886043381 |
GDF6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia, isolated |
| RS886043388 |
GPR179
|
Health Risk |
Pathogenic |
— |
| RS886043390 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS886043392 |
SGCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2D, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS886043399 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS886043401 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS886043402 |
TNPO3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1F, Autosomal dominant limb-girdle muscular dystrophy type 1F |
| RS886043403 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS886043405 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886043409 |
POMGNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS886043410 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome |
| RS886043412 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043414 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS886043417 |
MAK
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 62, Retinitis pigmentosa 62 |
| RS886043418 |
CFI
|
Health Risk |
Pathogenic/Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Age related macular degeneration 13 |
| RS886043419 |
GALC
|
Health Risk |
Pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS886043423 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS886043428 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS886043432 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS886043433 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043434 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886043437 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy |
| RS886043440 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043441 |
LOXHD1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS886043445 |
VPS33B
|
Health Risk |
Pathogenic |
— |
| RS886043448 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS886043451 |
JAG1
|
Health Risk |
Pathogenic |
— |
| RS886043453 |
CDKL5
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS886043454 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemiplegic migraine, Familial hemiplegic migraine |
| RS886043455 |
KCNT1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS886043456 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043459 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043460 |
SGCD
|
Health Risk |
Pathogenic |
— |
| RS886043462 |
TTN
|
Health Risk |
Likely pathogenic |
TTN-related disorder, Dilated cardiomyopathy 1G |
| RS886043463 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS886043464 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS886043466 |
TTLL5
|
Health Risk |
Likely pathogenic |
— |
| RS886043467 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043473 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043476 |
KDM6A
|
Health Risk |
Pathogenic |
— |
| RS886043477 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS886043479 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 1B, Zellweger spectrum disorders |
| RS886043487 |
ASXL3
|
Health Risk |
Pathogenic |
— |
| RS886043488 |
GPR179
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital stationary night blindness, Congenital stationary night blindness |
| RS886043489 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886043491 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS886043493 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Cardiomyopathy |
| RS886043494 |
STAMBP
|
Health Risk |
Pathogenic |
— |
| RS886043495 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS886043496 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043497 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS886043499 |
MPDZ
|
Health Risk |
Pathogenic |
— |
| RS886043504 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043505 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS886043506 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome 1, Inborn genetic diseases |
| RS886043511 |
HSD3B7
|
Health Risk |
Pathogenic |
HSD3B7-related disorder, HSD3B7-related disorder |
| RS886043512 |
CYP27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, CYP27A1-related disorder |
| RS886043514 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS886043519 |
COL6A3
|
Health Risk |
Pathogenic |
— |
| RS886043521 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043524 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS886043529 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043532 |
SCN1A
|
Health Risk |
Pathogenic |
— |
| RS886043534 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Inborn genetic diseases |
| RS886043540 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondyloperipheral dysplasia, Spondyloperipheral dysplasia |
| RS886043548 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS886043551 |
NEFL
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2E |
| RS886043552 |
ARX
|
Health Risk |
Pathogenic |
X-linked lissencephaly with abnormal genitalia, X-linked lissencephaly with abnormal genitalia |
| RS886043553 |
TRIM32
|
Health Risk |
Likely pathogenic |
— |
| RS886043554 |
COL6A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Ullrich congenital muscular dystrophy 1B, Bethlem myopathy 1A |
| RS886043555 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS886043556 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Inborn genetic diseases |
| RS886043558 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 1B, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS886043559 |
RAPSN
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 11 |
| RS886043561 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS886043565 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS886043571 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS886043572 |
PCDH19
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 9 |
| RS886043573 |
CRPPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2U, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS886043576 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, COL6A3-related disorder |
| RS886043582 |
TRPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Trichorhinophalangeal syndrome, type III |
| RS886043584 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886043587 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS886043590 |
LRP5
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 4, Osteoporosis with pseudoglioma |
| RS886043593 |
PKHD1
|
Health Risk |
Pathogenic |
— |
| RS886043595 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Hyperkalemic periodic paralysis |
| RS886043597 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886043598 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS886043603 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS886043605 |
JAG1
|
Health Risk |
Likely pathogenic |
JAG1-related disorder, JAG1-related disorder |
| RS886043606 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, JAG1-related disorder |
| RS886043609 |
ZEB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS886043610 |
CUL7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS886043612 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS886043613 |
FGFR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Genu varum, Short stature |
| RS886043616 |
LOXHD1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 77, LOXHD1-related disorder |
| RS886043619 |
FOXN1
|
Health Risk |
Likely pathogenic |
— |
| RS886043620 |
DCTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS886043622 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |